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1027-187 Baseline Brachial Artery Diameter Is a Predictor of 
Endothelial Function Assessed by Brachial Artery 
Vasoreactivity Testing
Michael Shechter, Dov Freimark, Vitali Usmanov, Micha S. Feinberg, Heart Institute, 
Sheba Medical Center, Tel Hashomer and Tel Aviv Univ, Israel
Background: Brachial artery vasoreactivity testing (BRT) is a non-invasive technique
used to evaluate flow-mediated vasodilation (FMD), an endothelium-dependent function.
Methods: To assess the impact of baseline brachial artery (BA) diameter on endothelial
function, we prospectively assessed FMD in 289 consecutive healthy subjects ( 213 men,
mean age 55±11 years) without coronary artery disease (CAD). After an overnight fast
endothelium-dependent FMD and endothelium-independent nitroglycerin-mediated
vasodilation (NTG) were assessed using high resolution (15 MHz) linear array ultra-
sound. Correlation analysis revealed a significant inverse association between baseline
BA diameter and FMD (r=-0.74, p<0.00001). No association was found between systolic
or diastolic blood pressure and BA diameter. Multivariate analysis demonstrated that
baseline BA diameter was an independent predictor of FMD. Severe endothelial dysfunc-
tion (<6% FMD) was observed in 27% of the patients. We therefore divided the study
population into 2 groups: Group A (n=78) with and Group B (n=211) without endothelial
dysfunction.
Results: Both groups were comparable with regard to CAD risk factors, age, gender,
body mass index, concomitant medications, lipids, resting heart rate and blood pressure
(Table).
Conclusion: Baseline BA diameter in healthy subjects is inversely associated with FMD
assesed by BRT independent of risk factors for CAD. The mechanism(s) responsible for
this relationship warrant exploration.
1027-188 Relationship of Polymorphisms in the Oxidative Stress-
Related Genes - Paraoxonase and p22phox - to Variant 
Angina and Coronary Artery Stenosis
Young-Seok Cho, Hyo-Soo Kim, Shu-Ying Zhang, Byung-Hee Oh, Myoung-Mook Lee, 
Young-Bae Park, Yun-Shik Choi, Seoul National University College of Medicine, Seoul, 
South Korea
Background: Oxidative stress plays an important role in the pathogenesis of coronary
atherosclerosis and spasm. We investigated whether the polymorphisms in two oxidative
stress-related genes, paraoxonase and p22phox, are associated with risks of coronary
artery spasm and stenosis. Methods: The study comprised of 116 patients with variant
angina, 118 patients with coronary artery stenosis, and 117 control subjects, who were
all classified by coronary angiography. In all three groups, the genotype frequencies of
the Q192R polymorphism of the paraoxonase gene and C242T polymorphism of the
p22phox gene were analyzed, and the serum thiobarbituric acid-reactive substance con-
centration was measured. Results: The frequency of the RR genotype of the paraoxo-
nase Q192R polymorphism was significantly higher in patients with variant angina and
coronary artery stenosis than in the control subjects(40.4% in variant angina and 37.8%
in coronary artery stenosis vs. 24.7% in control, p=0.020 and 0.048, respectively). From
the multivariate analysis, the odds ratio of the RR genotype was 2.240 for variant angina
(95% confidence interval; 1.012-4.956), and 2.333 for coronary artery stenosis (95%
confidence interval; 1.140-4.777), in relation to the control subjects. The thiobarbituric
acid-reactive substance level was significantly higher in the RR type than in the QQ+QR
types (RR vs. QQ+QR: 1.106 ± 0.420 nmol/mL vs. 0.949 ± 0.311 nmol/mL, p=0.028).
There was no significant difference in the prevalence of C242T polymorphism of the
p22phox gene between the three groups. Conclusion: The RR genotype of the paraoxo-
nase gene Q192R polymorphism was found to be an independent risk factor of both cor-
onary spasm and stenosis.
1027-189 Chronic Endothelin Receptor Antagonism Preserves 
Endothelial Function in a Transgenic Mouse Model of 
Alzheimer’s Disease
Ahmad A. Elesber, Piero Bonetti, Joerg Herrmann, Julie Woodrum, Steven Younkin, 
Lilach O. Lerman, Amir Lerman, Mayo Clinic, Rochester, MN
Background: Studies have demonstrated an association of Alzheimer disease (AD) with
cerebrovascular dysfunction and a number of cardiovascular risk factors, and thus possi-
bly with endothelial dysfunction. Endothelial dysfunction has been associated with an
increased release of endothelin-1 (ET-1). The current study was designed to test the
hypothesis that AD is associated with endothelial dysfunction and that chronic ET-1
antagonism improves endothelial function in a transgenic model of AD (Tg2576).
Methods: Three groups of mice were studied: C57BL/6 (normal control, n=6), Tg2576
(n=5), and Tg2576 fed Bosentan (100 mg/kg-1/day-1), a combined endothelin A and B
receptor antagonist for 4 months (Tg2576+Bosentan, n=5). Mice were sacrificed at the
age of seven months. Aortic artery vasorelaxation in response to the endothelium-depen-
dent vasodilator acetylcholine (Ach) was determined in vitro. 
Results: Maximum endothelium-dependent vasorelaxation of the aorta to Ach (10-5 mol/
L) was significantly attenuated in Tg2576 mice. In contrast, in Tg2576+Bosentan mice
endothelium-dependent vasorelaxation was similar to that observed in C57BL/6 mice
(see figure). There was no difference between the 3 groups in response to the non-
endothelial dependent vasodilator nitroprusside.
Conclusion: The current study demonstrates the presence of endothelial dysfunction in
an established murine model of AD and suggests a pathophysiological role for the
endogenous endothelin system in this disease process. 
1027-190 Whole-Body Insulin Resistance Precedes Vascular 
Insulin Resistance in a Murine Model of Diet-Induced 
Obesity
Brian T. Noronha, Stephen B. Wheatcroft, Jian-Mei Li, Ajay M. Shah, Mark T. Kearney, 
Kings College London, London, United Kingdom
Impaired nitric oxide (NO) bioactivity is a prominent feature of the vasculopathy associ-
ated with obesity and insulin resistance. Although insulin promotes endothelial NO pro-
duction, the mechanistic relationship between insulin resistance and endothelial
dysfunction is poorly defined. We tested the hypothesis that metabolic abnormalities pre-
cede endothelial dysfunction, using a model of diet-induced obesity in mice. Male C57b l
/6 mice receiving an obesogenic diet ( fat /carbohydrate -35%) from weaning were com-
pared with chow-fed controls. Body weight, glucocompetence, fasting insulin and triglyc-
erides, systolic blood pressure and vasomotor responses in aortic rings ex-vivo were
assessed after 4 and 8 weeks of feeding.
Mice receiving an obesogenic diet developed a typical metaboic syndrome with obesity,
hypertension, hyperglycemia, hyperinsulinemia and hypertriglyceridemia evident after 4
weeks. Whole-body insulin resistance, demonstrated by a blunted hypoglycemic
response to exogenous insulin (0.75u/kg i.p) was apparent by 4 weeks. In aortic rings
from control mice, preincubation with insulin (10mU/ml, 2 hours) significantly blunted the
maximal constriction to phenylephrine (PE;10microM). This vascular effect of insulin was
preserved in mice receiving an obesogenic diet for 4 weeks, but was lost after 8 weeks.
In conclusion, these data indicate that the development of whole-body insulin resistance
in a murine model of obesity, precedes insulin's NO dependent vasodilatory effects.
1027-191 Endothelial Dysfunction Accelerates Future 
Hypertensive Evolution and Causes Excess of Fatal 
Cardiovascular Events
Tatsuaki Murakami, Sumio Mizuno, Fukui Cardiovascular Center, Fukui, Japan
Introduction and hypothesis: We know little about the relationship between endothelial
dysfunction (ED) and hypertensive evolution (HTE). This study assessed hypothesis that
ED accelerates HTE. Methods: ED was graded by ultrasonic measured reactive
changes in lumen diameter of brachial artery after transient forearm occlusion (FMD;
flow-mediated endothelium-dependent vasodilation) in consecutive 518 patients with
suspected coronary artery disease. The enrolled patients were categorized into 3 groups
according to the values of FMD and we prospectively followed-up HTE and fatal cardio-
vascular events for 36 months or more. HTE was defined as two or more upstage of
hypertension or new administration of an antihypertensive agent. Results: For a mean
period of 57 months with 100% follow-up, the patients with severe endothelial dysfunction
(FMD<4%; Group-L, n=174) more frequently manifested HTE compared to Group-M with
mild endothelial dysfunction (4%<FMD<8%, n=171) plus Group-H with preserved endot-
helial function (FMD 8% or more, n=173), and more frequently resulted in cardiovascular
death. Cox proportional hazard model analysis including clinical variables showed that
severe endothelial dysfunction was the strongest predictor for HTE and the only predictor
for cardiovascular death. Conclusion: In conclusion, this is the first investigation demon-
strating that endothelial dysfunction increases future hypertensive evolution and cardio-
vascular death. 
Group A (n=78) Group B (n=211) p-value
Brachial artery diameter (mm) 6.06±1.00 5.33±0.91 <0.00001
%FMD 1.6±3.2 14.7±3.1 <0.000001
Results [mean]
Parameters Weight
(grams)
Epididymal
Fat 
pad (mg)
Systolic
BP 
(mmHg)
Fasting 
Blood sugar 
(mol/L)
Fasting 
Insulin 
(pg/ml)
Fasting 
Triglycerid
es (mol/L)
% Fall in blood 
sugar at 30 
mins after 
insulin (i.p)
% Change in PE 
E-max after 
insulin 
preincubation
Control
4 weeks
24.1 11.6 116  6.4  0.55  0.7 70.2 -26.2
High Fat
4 weeks
29.0  24.3 123.0 12.0 1.03  5.3 54.2  -28.6
p value <0.0001 <0.0001 <0.0001 <0.0001 <0.01 <0.0001 <0.0001 NS
Control
8 weeks
27.3 11.7 117.0 7.1 0.3 2.2 65.6 -18
High Fat
8 weeks
38.4 33.9 124.8 10.1 3. 5.4 48.4 +11.2
p value <0.0001  <0.0001 <0.0001 <0.0001 <0.0001 <0.0001  <0.0001 <0.05
Group-L Group-M Group-H Odds ratio P value
HTE 44 (25.2%) 17 (9.9%) 9 (5.2%) 2.87 <0.001
Cardiovascular death 9 (5.2%) 1 (0.6%) 1 (0.6%) 10.34 0.022
